PAVmed Inc. (PAVM)
PAVmed Statistics
Share Statistics
PAVmed has 17.09M shares outstanding. The number of shares has increased by 77.99% in one year.
| Shares Outstanding | 17.09M |
| Shares Change (YoY) | 77.99% |
| Shares Change (QoQ) | 51.67% |
| Owned by Institutions (%) | 11.97% |
| Shares Floating | 11.05M |
| Failed to Deliver (FTD) Shares | 2.03K |
| FTD / Avg. Volume | 1.15% |
Short Selling Information
The latest short interest is 385.5K, so 2.34% of the outstanding shares have been sold short.
| Short Interest | 385.5K |
| Short % of Shares Out | 2.34% |
| Short % of Float | 2.45% |
| Short Ratio (days to cover) | 2.65 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -1.73. PAVmed's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | -1.73 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for PAVmed.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06, with a Debt / Equity ratio of -0.01.
| Current Ratio | 0.06 |
| Quick Ratio | 0.06 |
| Debt / Equity | -0.01 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 988.6 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $76.79M |
| Profits Per Employee | $819.64M |
| Employee Count | 39 |
| Asset Turnover | 0.1 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.54B |
| Effective Tax Rate | -12.45% |
Stock Price Statistics
The stock price has increased by -63.59% in the last 52 weeks. The beta is 1.14, so PAVmed's price volatility has been higher than the market average.
| Beta | 1.14 |
| 52-Week Price Change | -63.59% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 0.89 |
| Relative Strength Index (RSI) | 51.75 |
| Average Volume (20 Days) | 177.13K |
Income Statement
In the last 12 months, PAVmed had revenue of 3B and earned 31.97B in profits. Earnings per share was 3.3.
| Revenue | 3B |
| Gross Profit | -1.84B |
| Operating Income | -44.49B |
| Net Income | 31.97B |
| EBITDA | -44.49B |
| EBIT | 28.38B |
| Earnings Per Share (EPS) | 3.3 |
Balance Sheet
The company has 1.19M in cash and 31.86M in debt, giving a net cash position of -30.68M.
| Cash & Cash Equivalents | 1.19M |
| Total Debt | 31.86M |
| Net Cash | -30.68M |
| Retained Earnings | -254.97B |
| Total Assets | 30.66M |
| Working Capital | -33.28M |
Cash Flow
In the last 12 months, operating cash flow was -33.55B and capital expenditures 0, giving a free cash flow of -33.55B.
| Operating Cash Flow | -33.55B |
| Capital Expenditures | 0 |
| Free Cash Flow | -33.55B |
| FCF Per Share | -3469.12 |
Margins
Gross margin is -61.6%, with operating and profit margins of -1485.38% and 1067.31%.
| Gross Margin | -61.6% |
| Operating Margin | -1485.38% |
| Pretax Margin | 949.15% |
| Profit Margin | 1067.31% |
| EBITDA Margin | -1485.38% |
| EBIT Margin | -1485.38% |
| FCF Margin | -1120.33% |
Dividends & Yields
PAVM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PAVM is $19, which is 2576.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $19 |
| Price Target Difference | 2576.1% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Dec 7, 2023. It was a backward split with a ratio of 1:15.
| Last Split Date | Dec 7, 2023 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -9.59 |
| Piotroski F-Score | 3 |